Construction of a prognostic model for radical esophagectomy based on immunohistochemical prognostic markers combined with clinicopathological factors

Esophageal squamous cell carcinoma (ESCC) has a poor prognosis and lacks effective biomarkers to evaluate prognosis and treatment. Glycoprotein nonmetastatic melanoma protein B (GPNMB) is a protein highly expressed in ESCC tissues screened by isobaric tags for relative and absolute quantitation proteomics, which has significant prognostic value in a variety of malignant tumors, but its relationship with ESCC remains unclear. By immunohistochemical staining of 266 ESCC samples, we analyzed the relationship between GPNMB and ESCC. To explore how to improve the ability of ESCC prognostic assessment, we established a prognostic model of GPNMB and clinicopathological features. The results suggest that GPNMB expression is generally positive in ESCC tissues and is significantly associated with poorer differentiation, more advanced American Joint Council on Cancer (AJCC) stage, and higher tumor aggressiveness (P < .05). Multivariate Cox analysis indicated that GPNMB expression was an independent risk factor for ESCC patients. A total of 188 (70%) patients were randomly selected from the training cohort and the four variables were automatically screened by stepwise regression based on the AIC principle: GPNMB expression, nation, AJCC stage and nerve invasion. Through the weighted term, we calculate the risk score of each patient, and by drawing the receiver operating characteristic curve, we show that the model has good prognostic evaluation performance. The stability of the model was verified by test cohort. Conclusion: GPNMB is a prognostic marker consistent with the characteristics of tumor therapeutic targets. For the first time, we constructed a prognostic model combining immunohistochemical prognostic markers and clinicopathological features in ESCC, which showed higher prognostic efficacy than AJCC staging system in predicting the prognosis of ESCC patients in this region.

[1]  Qiqi Zhang,et al.  Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma. , 2022, Journal of proteomics.

[2]  M. Nakayama,et al.  Glycoprotein NMB promotes tumor formation and malignant progression of laryngeal squamous cell carcinoma , 2022, Cancer science.

[3]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[4]  K. Matsuo,et al.  Significance of Antimicrobial Prophylaxis for the Prevention of Early-Onset Pneumonia After Radical Esophageal Cancer Resection: A Retrospective Analysis of 356 Patients Undergoing Thoracoscopic Esophagectomy , 2021, Annals of Surgical Oncology.

[5]  Hiroyuki Suzuki,et al.  Glycoprotein non–metastatic melanoma protein B functions with growth factor signaling to induce tumorigenesis through its serine phosphorylation , 2021, Cancer science.

[6]  Chun-Yu Liu,et al.  Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer , 2021, Scientific Reports.

[7]  Dae Joon Kim,et al.  Prognostic effect of perineural invasion in surgically treated esophageal squamous cell carcinoma , 2021, Thoracic cancer.

[8]  Szu-Hua Pan,et al.  N‐glycosylated GPNMB ligand independently activates mutated EGFR signaling and promotes metastasis in NSCLC , 2021, Cancer science.

[9]  Shuan Rao,et al.  Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade , 2020, Frontiers in Oncology.

[10]  Jian Sun,et al.  A multi-kinase inhibitor APG-2449 enhances the antitumor effect of Ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition. , 2020, Biochemical pharmacology.

[11]  Y. Li,et al.  Clinical significance of HDAC1, -2 and -3 expression levels in esophageal squamous cell carcinoma , 2020, Experimental and therapeutic medicine.

[12]  I. Katayama,et al.  GPNMB is expressed in human epidermal keratinocytes but disappears in the vitiligo lesional skin , 2020, Scientific Reports.

[13]  Yanqiao Zhang,et al.  Survival and prognostic factors of patients with esophageal fistula in advanced esophageal squamous cell carcinoma , 2020, Bioscience reports.

[14]  Q. Xue,et al.  Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy , 2019, Annals of Surgical Oncology.

[15]  Xiao-bin Cui,et al.  Three-gene immunohistochemical panel predicts progression and unfavorable prognosis in esophageal squamous cell carcinoma. , 2019, Human pathology.

[16]  X. Zhang,et al.  Multicellular gene network analysis identifies a macrophage-related gene signature predictive of therapeutic response and prognosis of gliomas , 2019, Journal of Translational Medicine.

[17]  Bin Zhang,et al.  Single-Port Inflatable Mediastinoscopy Combined With Laparoscopic-Assisted Small Incision Surgery for Radical Esophagectomy Is an Effective and Safe Treatment for Esophageal Cancer , 2019, Journal of Gastrointestinal Surgery.

[18]  Zhijun Sun,et al.  High expression of GPNMB predicts poor prognosis in head and neck squamous cell carcinoma. , 2019, Histology and histopathology.

[19]  Ming Chen,et al.  Prognostic value of immunohistochemical factors in esophageal small cell carcinoma (ESCC): analysis of clinicopathologic features of 73 patients. , 2018, Journal of thoracic disease.

[20]  Xiaoqian Zhou,et al.  GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway. , 2018, Oncology reports.

[21]  S. Dawsey,et al.  Screening for esophageal squamous cell carcinoma: recent advances. , 2018, Gastrointestinal endoscopy.

[22]  Hong-yan Cheng,et al.  Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer , 2018, Archives of Gynecology and Obstetrics.

[23]  Y. Nie,et al.  Prognostic value of an immunohistochemical signature in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy , 2018, Molecular oncology.

[24]  S. Hammes,et al.  Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB) and Cancer: A Novel Potential Therapeutic Target , 2017, Steroids.

[25]  D. Tian,et al.  Association of roasting meat intake with the risk of esophageal squamous cell carcinoma of Kazakh Chinese via affecting promoter methylation of p16 gene. , 2014, Asia Pacific journal of clinical nutrition.

[26]  J. Yun,et al.  The prognostic effect of perineural invasion in esophageal squamous cell carcinoma , 2014, BMC Cancer.

[27]  M. Yashiro,et al.  The impact of combined thoracoscopic and laparoscopic surgery on pulmonary complications after radical esophagectomy in patients with resectable esophageal cancer. , 2014, Anticancer research.

[28]  Lianghai Wang,et al.  Hypermethylation of miR-34b/c is associated with early clinical stages and tumor differentiation in Kazakh patients with esophageal squamous cell carcinoma. , 2019, International journal of clinical and experimental pathology.

[29]  Lennart Martens,et al.  iTRAQ Data Interpretation , 2012, Quantitative Methods in Proteomics.